Scientists have created nearly a dozen new lines of human embryonic stem (ES) cells that for the first time carry the genetic signature of diseased or injured patients.

The Institute of Medicine (IOM) has released a comprehensive report on future directions of spinal cord injury research.

This position paper outlines issues that should be considered in the planning, initiation, and conduct of human clinical trials in SCI.

Dr. Kim Anderson conducted a novel survey identifying the areas of partial recovery that were most important to the SCI population. This report may be especially useful for grant applicant research initiatives.

This paper summarizes information presented at the International Clinical Trials Workshop on Spinal Cord Injury, held in Vancouver, Canada in February 2004.